These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26685991)

  • 1. The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.
    Trevlopoulou A; Touzlatzi N; Pitsikas N
    Psychopharmacology (Berl); 2016 Mar; 233(6):1045-54. PubMed ID: 26685991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats.
    Georgiadou G; Grivas V; Tarantilis PA; Pitsikas N
    Psychopharmacology (Berl); 2014 Feb; 231(4):717-26. PubMed ID: 24096536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia.
    Lafioniatis A; Orfanidou MA; Papadopoulou ES; Pitsikas N
    Behav Brain Res; 2016 Aug; 309():14-21. PubMed ID: 27132765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats.
    Zoupa E; Gravanis A; Pitsikas N
    Neuropharmacology; 2019 Jun; 151():74-83. PubMed ID: 30959020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat.
    Katsanou L; Fragkiadaki E; Kampouris S; Konstanta A; Vontzou A; Pitsikas N
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated but not acute exposure with a low dose range of the nitric oxide (NO) donor sodium nitroprusside (SNP) induces anxiolytic-like behaviour in a dose-independent manner in two different rat models of anxiety.
    Papageorgoulis A; Fallon P; Mpalantes N; Papageorgouli D; Pitsikas N
    Nitric Oxide; 2020 Jun; 99():1-6. PubMed ID: 32194244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and repeated exposure with the nitric oxide (NO) donor sodium nitroprusside (SNP) differentially modulate responses in a rat model of anxiety.
    Orfanidou MA; Lafioniatis A; Trevlopoulou A; Touzlatzi N; Pitsikas N
    Nitric Oxide; 2017 Sep; 69():56-60. PubMed ID: 28522342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the nitric oxide donor sodium nitroprusside in the antidepressant effect of ketamine in mice.
    Vogt MA; Vogel AS; Pfeiffer N; Gass P; Inta D
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1848-52. PubMed ID: 26138155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
    Pitsikas N; Zisopoulou S; Sakellaridis N
    J Neurosci Res; 2006 Aug; 84(2):299-305. PubMed ID: 16710846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
    Nikiforuk A; Hołuj M; Kos T; Popik P
    Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
    Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE
    BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety.
    Kalouda T; Pitsikas N
    Pharmacol Biochem Behav; 2015 Nov; 138():111-6. PubMed ID: 26363313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crocins, the active constituents of Crocus sativus L., counteracted apomorphine-induced performance deficits in the novel object recognition task, but not novel object location task, in rats.
    Pitsikas N; Tarantilis PA
    Neurosci Lett; 2017 Mar; 644():37-42. PubMed ID: 28216334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine.
    Pitsikas N; Sakellaridis N
    Eur J Pharmacol; 2007 Oct; 571(2-3):174-9. PubMed ID: 17628527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthetic ketamine impairs rats' recall of previous information: the nitric oxide synthase inhibitor N-nitro-L-arginine methylester antagonizes this ketamine-induced recognition memory deficit.
    Boultadakis A; Pitsikas N
    Anesthesiology; 2011 Jun; 114(6):1345-53. PubMed ID: 21478733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats.
    Marszalek-Grabska M; Gibula-Bruzda E; Jenda M; Gawel K; Kotlinska JH
    Brain Res; 2016 Jul; 1642():389-396. PubMed ID: 27085203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nitric oxide-releasing derivative of ferulic acid NCX 2057 antagonized delay-dependent and scopolamine-induced performance deficits in a recognition memory task in the rat.
    Boultadakis A; Liakos P; Pitsikas N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):5-9. PubMed ID: 19744535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
    Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
    Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic prenatal MK-801 treatment on object recognition, cognitive flexibility, and drug-induced locomotor activity in juvenile and adult rat offspring.
    Gallant S; Welch L; Martone P; Shalev U
    Behav Brain Res; 2017 Jun; 328():62-69. PubMed ID: 28390877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.